Utility of new classification based on clinical and lesional factors after self-expandable nitinol stenting in the superficial femoral artery

Soga, Yoshimitsu; Iida, Osamu; Hirano, Keisuke; Suzuki, Kenji; Tosaka, Atsushi; Yokoi, Hiroyoshi; Nobuyoshi, Masakiyo

doi:10.1016/j.jvs.2011.03.286

Cited by 80 publications

(78 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The favorable primary patency rate in the present study was therefore attributable to the lower prevalence of CTO lesions relative to that in the previous study. In addition, the present study identified hemodialysis as a predictor of the loss of primary patency, which was consistent with previous reports in which patients undergoing hemodialysis had an increased risk of the loss of primary patency after EVT or self‐expandable nitinol stent implantation in FP lesions .…”

Section: Discussionsupporting

confidence: 92%

Long‐term outcomes of SMART stent implantation in patients with femoro‐popliteal disease

Matsumi

Tobita

Shishido

et al. 2016

Cathet Cardio Intervent

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 92%

Long‐term outcomes of SMART stent implantation in patients with femoro‐popliteal disease

Matsumi

Tobita

Shishido

et al. 2016

Cathet Cardio Intervent

View full text Add to dashboard Cite

show abstract

“…Recent studies are suggesting that patients with SFPA disease can have long-term results comparable to bypass surgery when treatment options are well matched to patient-specific and anatomic characteristics [23]. FeDCLIP score [24] is a score using the six items of female, diabetes, dialysis, critical limb ischemia, lesion length of >150 mm, and poor runoff, to predict patency and mortality after self-expanding nitinol stent implantation in the superficial femoral artery.…”

Section: Discussionmentioning

confidence: 99%

TCT-537 Long-term Outcomes of Self-Expanding Nitinol Stent Implantation for Chronic Total Occlusion of the Superficial Femoral and Proximal Popliteal Artery

Sakamoto

Hirano

Kato

et al. 2013

Journal of the American College of Cardiology

Self Cite

View full text Add to dashboard Cite

Objective: To investigate the 5-year patency rates and predictors of restenosis after self-expanding nitinol stent implantation for chronic total occlusion (CTO) in superficial femoral and proximal popliteal artery (SFPA) lesions. Background: Outcomes and longterm patency rates after self-expanding nitinol stent for CTO in the SFPA lesions have not been clarified. Methods: From January 2004 to December 2009, 861 serial arteriosclerosis obliterans patients, 1,017 limbs, underwent endovascular therapy with implantation of a self-expanding nitinol stent for SFPA lesions at four institutions in Japan. Of the cohort, 352 patients, 383 limbs, had self-expanding nitinol stents implanted for CTOs in the SFPA and were followed for 5 years. We retrospectively investigated patency rate and multivariate predictors associated with restenosis. Results: Mean age was 72 6 9 years and 31% were female patients. In total, 58% of the patients had diabetes mellitus and 25% were patients with critical limb ischemia. Occluded length was 194 6 89 mm, mean total stent length was 198 6 7 mm, and mean stent diameter was 7.1 6 0.9 mm. Five-year primary and secondary patency rates were 51.8 and 79.5%, respectively, and the rates of freedom from bypass surgery, major or minor amputation, and all-cause death were 96.1, 96.2, and 78.4%, respectively. Female gender (odds ratio, 1.95; P 5 0.0051) and mean stent diameter (odds ratio, 0.77; P 5 0.0324) were factors strongly associated with restenosis. Conclusions: Women and patients requiring small stents failed to maintain primary patency when treated with self-expanding nitinol stents for CTO lesions in the SFPA. Although primary patency was low, the secondary patency rate was acceptable. V C 2013 Wiley Periodicals, Inc.

show abstract

“…Although self‐expandable nitinol stent implantation in SFA reduces restenosis compared to balloon angioplasty, restenosis remains a concerning issue . Although some reports have stated that patients with HD (HD+) have an increased risk for restenosis or loss of patency after stent implantation in SFA , only few studies have described the risk of restenosis and the long‐term outcomes after EVT for SFA occlusive disease in HD+. Therefore, this study compares the risks for loss of primary patency (PP), secondary patency (SP), and amputation‐free survival (AFS) after EVT for SFA occlusive disease between HD+ and those without HD (HD−).…”

Section: Introductionmentioning

confidence: 99%

Comparison of long‐term patency after endovascular therapy for superficial femoral artery occlusive disease between patients with and without hemodialysis

Matsumi

Tobita

Shishido

et al. 2015

Cathet Cardio Intervent

View full text Add to dashboard Cite

show abstract

Utility of new classification based on clinical and lesional factors after self-expandable nitinol stenting in the superficial femoral artery

Abstract: New classification schemes based on FeDCLIP score were useful for risk stratification in vessel patency and mortality after self-expandable nitinol stenting for SFA disease.

Cited by 80 publications

References 19 publications

Long‐term outcomes of SMART stent implantation in patients with femoro‐popliteal disease

Long‐term outcomes of SMART stent implantation in patients with femoro‐popliteal disease

TCT-537 Long-term Outcomes of Self-Expanding Nitinol Stent Implantation for Chronic Total Occlusion of the Superficial Femoral and Proximal Popliteal Artery

Comparison of long‐term patency after endovascular therapy for superficial femoral artery occlusive disease between patients with and without hemodialysis

Contact Info

Product

Resources

About